Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trialAndrew R. Clamp, Jonathan A. Ledermann, Elizabeth C James et al.|The Lancet Oncology|2022Cited by 45
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockadeJuan Carlos Yam‐Puc, James Thaventhiran, Aleksei Lulla et al.|Nature Communications|2023Cited by 45
Age-Associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockadeJuan Carlos Yam‐Puc, James Thaventhiran, Zhaleh Hosseini et al.|medRxiv|2022Cited by 3